RxDoctor Payments Data

Brian Chou

Optometrist · San Diego, CANPI 1013960996

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $185,798 of the $243,052 with a category attached, or 76.4%. Alcon Research LLC accounts for 76.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $173,651 and has fallen 99.8% since, to $426 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$243,052in general payments, 2019–2025

Across 90 payments — averaging $2700.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$186K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$37K
  • Bausch & Lomb Americas Inc.$19K
  • Glaukos Corporation$545
  • Coopervision Inc.$374
  • Alcon$204
  • plus $62 from 2 others

What the payments were for

  • Royalty or licence$185,79876%
  • Consulting fees$7750%
  • Speaking & faculty fees$45,67519%
  • Travel & lodging$7,9623%
  • Food & beverage$2,8421%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$243,052 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.

See all optometrist providers in California

Medicare billing

Part B allowed, 2024
$1,500
Medicare patients
14
Services billed
14

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →